Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
AssigneeThe William M. Yanbrough Foundation
InventorMichael E. Silver
Life of this patent
Estimating the term…
Abstract
A method for treating benign prostatic hyperplasia (BPH), prostatitis, and/or prostate cancer, including the step of administering an isothiocyanate functional surfactant to a patient affected by benign prostatic hyperplasia, prostatitis, and/or prostate cancer. In a preferred embodiment, the protonated form of the isothiocyanate functional surfactant is represented by the following chemical structure:
Claims19
A method for treating benign prostatic hyperplasia (BPH), prostatitis, and/or prostate cancer, comprising the step of:
- administering an isothiocyanate functional surfactant to a patient affected by benign prostatic hyperplasia, prostatitis, and/or prostate cancer.
A method for treating benign prostatic hyperplasia, comprising the step of:
- administering an isothiocyanate functional surfactant to a patient affected by benign prostatic hyperplasia, wherein the protonated form of the isothiocyanate functional surfactant is represented by the following chemical structure:
A method for treating prostatitis, comprising the step of:
- administering an isothiocyanate functional surfactant to a patient affected by prostatitis, wherein the protonated form of the isothiocyanate functional surfactant is represented by the following chemical structure:
Dependencies are inferred from the claim text.